15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $10M | -$251M | 0.0% | -1141.1% | -$90M | $93M | $30M |
| 2024 | $4M | -$126M | 0.0% | -3440.2% | -$77M | $0 | $30M |
| 2023 | $6M | -$96M | 0.0% | -1602.5% | -$68M | — | $8M |
| 2022 | $27M | $28M | 0.0% | 0.0% | -$70M | $86M | $5M |
| 2021 | $14M | -$92M | 0.0% | 0.0% | -$63M | $180M | $36M |
| 2020 | $32M | -$171M | 0.0% | 0.0% | -$85M | $172M | $52M |
| 2019 | $91M | -$322M | 0.0% | 0.0% | -$174M | $218M | $66M |
| 2018 | $151M | -$509M | 0.0% | -334.4% | -$166M | $212M | $97M |
| 2017 | $219M | -$117M | 84.8% | -62.8% | -$150M | $8M | $68M |
| 2016 | $191M | -$187M | 80.2% | -65.6% | -$81M | $8M | $63M |
| 2015 | — | -$84M | — | — | $23M | $9M | $136M |
| 2014 | — | -$82M | — | — | -$26M | $10M | $27M |
| 2013 | — | -$39M | — | — | -$55M | $2M | $50M |
| 2012 | — | -$82M | — | — | -$69M | — | $10M |
| 2011 | — | -$85M | — | — | -$95M | — | $20M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $23M | -$8M | 0.0% | -25.8% | -$44M | $94M | $7M |
| Dec '25 | — | -$24M | — | — | -$23M | $93M | $30M |
| Sep '25 | — | -$146M | — | — | -$29M | $93M | $14M |
| Jun '25 | — | -$27M | — | — | -$20M | — | $14M |
| Mar '25 | $1M | -$54M | 0.0% | -1685.0% | -$17M | — | $6M |
| Dec '24 | — | -$20M | — | — | -$9M | $0 | $30M |
| Sep '24 | — | -$24M | — | — | -$24M | — | $25M |
| Jun '24 | — | -$59M | — | — | -$25M | — | $9M |
| Mar '24 | — | -$24M | — | — | -$18M | — | $17M |
| Dec '23 | — | -$33M | — | — | -$17M | — | $8M |
| Sep '23 | — | -$20M | — | — | -$17M | — | $10M |
| Jun '23 | $2M | -$20M | 0.0% | 0.0% | -$16M | — | $17M |
| Mar '23 | $2M | -$23M | 0.0% | 0.0% | -$19M | — | $10M |
| Dec '22 | $2M | -$22M | 0.0% | 0.0% | -$15M | $86M | $5M |
| Sep '22 | $17M | $87M | 0.0% | 0.0% | -$25M | $82M | $9M |
| Jun '22 | $3M | -$18M | 0.0% | 0.0% | -$9M | $199M | $44M |
| Mar '22 | $6M | -$19M | 0.0% | 0.0% | -$20M | $201M | $40M |
| Dec '21 | $4M | -$25M | 0.0% | 0.0% | -$17M | $180M | $36M |
| Sep '21 | $3M | -$30M | 0.0% | 0.0% | -$19M | $180M | $42M |
| Jun '21 | $4M | -$20M | 0.0% | 0.0% | -$9M | $177M | $36M |
How the market has priced PGEN against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Precigen, Inc.'s revenue has declined 21.3% per year. These are computed facts, not advice.
As of FY2025, Precigen, Inc. reported $93M of total debt against $30M of cash; operating income covered interest expense -28.6×.
In FY2025, gross margin was —, operating margin -1141.1%, and net margin -2587.8%.
As of Jun '26, Precigen, Inc. traded at a price-to-earnings ratio of about 16.9× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.